J Jylhava
Overview
Explore the profile of J Jylhava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kananen L, Eriksdotter M, Bostrom A, Kivipelto M, Annetorp M, Metzner C, et al.
Clin Nutr
. 2021 Aug;
41(12):2973-2979.
PMID: 34389208
Background & Aims: Overweight and obesity have been consistently reported to carry an increased risk for poorer outcomes in coronavirus disease 2019 (COVID-19) in adults. Existing reports mainly focus on...
2.
Kananen L, Enroth L, Raitanen J, Jylhava J, Burkle A, Moreno-Villanueva M, et al.
Sci Rep
. 2021 Mar;
11(1):6139.
PMID: 33731775
Self-rated health (SRH) is one of the most frequently used indicators in health and social research. Its robust association with mortality in very different populations implies that it is a...
3.
Kananen L, Hurme M, Jylha M, Harkanen T, Koskinen S, Stenholm S, et al.
Sci Rep
. 2020 Aug;
10(1):13809.
PMID: 32796872
Increased levels of circulating cell-free DNA (cf-DNA) are associated with and predict poor health outcomes. However, its predictive ability for mortality in population-based samples remains understudied. We analysed the capability...
4.
Rannikko J, Seiskari T, Huttunen R, Tarkiainen I, Jylhava J, Hurme M, et al.
J Intern Med
. 2018 Apr;
284(4):418-426.
PMID: 29687943
Background: A few studies have shown that both quick Sequential Organ Failure Assessment (qSOFA) score and cell-free DNA (cfDNA) have potential use as a prognostic marker in patients with infection....
5.
Kananen L, Marttila S, Nevalainen T, Kummola L, Junttila I, Mononen N, et al.
Age (Dordr)
. 2016 Jun;
38(3):65.
PMID: 27300324
The epigenetic clock, defined as the DNA methylome age (DNAmAge), is a candidate biomarker of ageing. In this study, we aimed to characterize the behaviour of this marker during the...
6.
Kananen L, Marttila S, Nevalainen T, Jylhava J, Mononen N, Kahonen M, et al.
BMC Genomics
. 2016 Feb;
17:103.
PMID: 26861258
Background: Chronological aging-associated changes in the human DNA methylome have been studied by multiple epigenome-wide association studies (EWASs). Certain CpG sites have been identified as aging-associated in multiple studies, and...
7.
Nevalainen T, Kananen L, Marttila S, Jylha M, Hervonen A, Hurme M, et al.
Age (Dordr)
. 2015 Jul;
37(4):9814.
PMID: 26188803
Aging is associated with a pro-inflammatory state, often referred to as inflammaging. The origin of the pro-inflammatory mediators and their role in the pathogenesis of the aging-associated diseases remain poorly...
8.
Haarala A, Kahonen M, Lehtimaki T, Aittoniemi J, Jylhava J, Hutri-Kahonen N, et al.
Clin Exp Immunol
. 2012 Jan;
167(2):309-16.
PMID: 22236008
Human cytomegalovirus (CMV) infection is associated with a higher risk of cardiovascular disease in immunocompromised organ transplant patients. It has been linked with the pathogenesis of elevated arterial blood pressure....
9.
Kuparinen T, Seppala I, Jylhava J, Marttila S, Aittoniemi J, Kettunen J, et al.
Genes Immun
. 2011 Oct;
13(2):184-90.
PMID: 21993531
Cytomegalovirus (CMV) causes an infection, which is followed by a lifelong latency. CMV has received much attention in clinical studies, but little is known about the genetic basis of this...
10.
Jylhava J, Haarala A, Kahonen M, Lehtimaki T, Jula A, Moilanen L, et al.
Clin Exp Immunol
. 2011 Mar;
164(2):211-7.
PMID: 21391986
Pentraxin 3 (PTX3) is a novel candidate immunoinflammatory marker that has been reported to be associated with cardiometabolic risk factors and to predict adverse outcomes in individuals with cardiovascular disease...